Humana Inc. (NYSE:HUM) Shares Sold by Kestra Private Wealth Services LLC

Kestra Private Wealth Services LLC decreased its holdings in Humana Inc. (NYSE:HUM) by 4.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,543 shares of the insurance provider’s stock after selling 117 shares during the quarter. Kestra Private Wealth Services LLC’s holdings in Humana were worth $645,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. International Assets Investment Management LLC lifted its position in shares of Humana by 261,025.1% during the 3rd quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider’s stock valued at $2,340,660,000 after buying an additional 738,701 shares in the last quarter. FMR LLC grew its position in shares of Humana by 23.4% in the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock valued at $1,073,387,000 after purchasing an additional 643,291 shares during the period. Thrivent Financial for Lutherans increased its stake in shares of Humana by 55.6% during the third quarter. Thrivent Financial for Lutherans now owns 600,317 shares of the insurance provider’s stock worth $190,145,000 after purchasing an additional 214,535 shares in the last quarter. Retirement Systems of Alabama raised its position in shares of Humana by 735.9% during the 4th quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock worth $55,563,000 after purchasing an additional 192,801 shares during the last quarter. Finally, Pzena Investment Management LLC lifted its stake in Humana by 8.1% in the 3rd quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider’s stock valued at $793,830,000 after buying an additional 187,903 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

HUM has been the subject of several research reports. Barclays boosted their price objective on Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a research note on Thursday. Bank of America raised Humana from an “underperform” rating to a “neutral” rating and increased their price objective for the company from $247.00 to $308.00 in a research note on Wednesday, November 6th. Piper Sandler lifted their target price on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 15th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $290.00 target price on shares of Humana in a research report on Wednesday. Finally, TD Cowen boosted their price target on shares of Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Nineteen investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $293.05.

Insider Buying and Selling

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.32% of the stock is owned by corporate insiders.

Humana Price Performance

Shares of HUM opened at $253.61 on Friday. The firm has a 50-day simple moving average of $271.83 and a two-hundred day simple moving average of $295.17. The stock has a market cap of $30.54 billion, a PE ratio of 22.46, a P/E/G ratio of 2.11 and a beta of 0.56. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM) last posted its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.18% and a return on equity of 13.20%. As a group, analysts forecast that Humana Inc. will post 16.11 EPS for the current year.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.